Quick Answer
REGENXBIO Inc. reported Net Income of -$193.88 million for fiscal year 2025.
REGENXBIO Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$193.88M | +14.6% |
| 2024 | -$227.10M | +13.8% |
| 2023 | -$263.49M | +6.0% |
| 2022 | -$280.32M | -319.3% |
| 2021 | $127.84M | +214.9% |
| 2020 | -$111.25M | -17.4% |
| 2019 | -$94.73M | -194.8% |
| 2018 | $99.94M | +236.6% |
| 2017 | -$73.17M | -16.2% |
| 2016 | -$62.97M | -176.0% |
| 2015 | -$22.81M | -469.8% |
| 2014 | -$4.00M | +25.7% |
| 2013 | -$5.39M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$61.94M | -3.9% | +12.6% |
| June 30, 2025 | -$70.87M | -33.7% | -1265.1% |
| March 31, 2025 | $6.08M | +109.6% | +110.2% |
| September 30, 2024 | -$59.60M | +3.7% | -12.5% |
| June 30, 2024 | -$52.99M | +26.5% | +16.3% |
| March 31, 2024 | -$63.33M | +5.0% | -2.4% |
| September 30, 2023 | -$61.87M | +18.0% | +14.1% |
| June 30, 2023 | -$72.06M | -5.7% | -8.1% |
- REGENXBIO Inc. showed an increase of +14.6% in Net Income compared to the prior fiscal year.
- Over the 2013–2025 period, REGENXBIO Inc.’s net income has declined by 3499.0% (from -$5.39 million to -$193.88 million).
- The most recent figure is from REGENXBIO Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: